Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
Does chemo permanently damage myeloma immune function? Especially if the MM patient in question undergoes round after round of aggressive therapies?
When a person is first diagnosed with myeloma they rarely think about long-term health issues. All we NDMM patients think about is reaching complete remission or becoming cancer-free.
But when I recently read studies saying that:
I found myself consumed by the idea of MM patients supporting their immune system during the cycle of MM therapies- the cycle of treatment, remission, relapse again and again until MDR.
Read how Chat GPT responded to my question of whether chemo kills myeloma immune function-
Does chemotherapy permanently damage the immune system of myeloma patients?
Chemotherapy can significantly impact the immune system of multiple myeloma patients, but whether the damage is permanent depends on several factors, including the type and intensity of chemotherapy, the patient’s overall health, and whether they undergo a stem cell transplant.
Other than IVIG therapy, what can oncology do to boost the immune function of MM patients? Though oncology can prescribe therapies such as antibiotics to protect MM patients from infection, I don’t know of many conventional immune boosting therapies.
Fortunately, there are a variety of evidence-based non-conventional therapies shown to boost t-cells, b-cells, NK cells, etc. Something to consider…
I am a MM survivor and cancer coach. Email me at David.PeopleBeatingCancer@gmail.com if you have questions about immune boosting therapies.
Hang in there,
David Emerson
“Key Points
Abstract
Engineered T-cell therapies have demonstrated impressive clinical responses in patients with hematologic malignancies. Despite this efficacy, many patients have a transient persistence of T cells, which can be correlated with transient clinical response.
Translational data on T cells from pediatric cancer patients shows a progressive decline in chimeric antigen receptor (CAR) suitability with cumulative chemotherapy regardless of regimen.
We investigated the effects of chemotherapy on surviving T cells in vitro, describing residual deficits unique to each agent including mitochondrial damage and metabolic alterations. In the case of cyclophosphamide but not doxorubicin or cytarabine, these effects could be reversed with N-acetylcysteine.
Specifically, we observed that surviving T cells could be stimulated, expanded, and transduced with CARs with preserved short-term cytolytic function but at far lower numbers and with residual metabolic deficits…
Overview
N-acetyl cysteine (NAC) comes from the amino acid L-cysteine. Amino acids are building blocks of proteins. NAC has many uses and is an FDA approved drug.
N-acetyl cysteine is an antioxidant that might play a role in preventing cancer. As a drug, it’s used by healthcare providers to treat acetaminophen (Tylenol) poisoning. It works by binding the poisonous forms of acetaminophen that are formed in the liver…
chemo permanently damage myeloma immune function chemo permanently damage myeloma immune function chemo permanently damage myeloma immune function